FDA Approved: TIBSOVO — Supplemental Application (Servier Pharmaceutical LLC)

View source ↗

Summary

The FDA approved a supplemental application for TIBSOVO (ivosidenib) submitted by Servier Pharmaceutical LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tibsovo (ivosidenib)

Snippet

SUPPL AP for TIBSOVO (IVOSIDENIB)